Author

Jeanine M. Cordova

Observed names: Cordova, Jeanine, JEANINE M. CORDOVA, Jeanine Cordova

Institution: Amgen (United States)

Observed institutions: Amgen (United States), Boehringer Ingelheim (United States), Arizona State University, University of Pennsylvania

OpenAlex ID: A5017403253

Gene and MicroRNA Expression Responses to Exercise; Relationship with Insulin Sensitivity

2015 · Carrie S. McLean, Clinton Mielke, et al. · PLoS ONE · 60

Design of a Functional Membrane Protein by Engineering a Heme-Binding Site in Glycophorin A

2006 · Jeanine M. Cordova, Pamela L. Noack, et al. · Journal of the American Chemical Society · 56

Adenine Nucleotide Translocase Is Acetylated in Vivo in Human Muscle: Modeling Predicts a Decreased ADP Affinity and Altered Control of Oxidative Phosphorylation

2014 · Clinton Mielke, Natalie Lefort, et al. · Biochemistry · 52

Modulation of function in a minimalist heme-binding membrane protein

2012 · Sandip Shinde, Jeanine M. Cordova, et al. · JBIC Journal of Biological Inorganic Chemistry · 32

A risk prediction model for heart failure hospitalization in type 2 diabetes mellitus

2019 · Brent A. Williams, Daniela Geba, et al. · Clinical Cardiology · 29

Quantifying the Risk Continuum for Cardiovascular Death in Adults with Type 2 Diabetes

2021 · Brent A. Williams, James C. Blankenship, et al. · Canadian Journal of Diabetes · 8

Heart failure documentation in outpatients with diabetes and volume overload: an observational cohort study from the Diabetes Collaborative Registry

2020 · Suzanne V. Arnold, Philip G. Jones, et al. · Cardiovascular Diabetology · 5

2234-PUB: A Risk Prediction Model for End-Stage Renal Disease in Patients with Type 2 Diabetes Mellitus

2019 · DANIELA GEBA, JEANINE M. CORDOVA, et al. · Diabetes · 4

Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and Race

2020 · Byron J. Hoogwerf, Michele MacKenzie, et al. · Diabetes Therapy · 2

0068Real-world Change in Cardiometabolic Markers After Glucagon-like Peptide-1 (GLP-1)-Based Treatment Discontinuation Among US Patients with ASCVD

2026 · Daniel Edmonston, Nadia M. Chu, et al. · American Heart Journal

Real-world insights into antiobesity medications in an online patient community: a feasibility study

2026 · Bethany Kalich, Marisa Cruz, et al. · medRxiv

Abstract 4365696: Virtual Decentralized Study of Patient Nausea Experience on Anti-Obesity Medication (COSMOS-DIGITAL)

2025 · Bethany Kalich, Marisa Cruz, et al. · Circulation

A Prediction Model for Identifying Type 2 Diabetics at Highest Risk of Cardiorenal Outcomes

2019 · Brent Williams, Daniela Geba, et al. · Journal of Cardiac Failure

421-P: Documentation of Heart Failure in Outpatients with Type 2 Diabetes and Evidence of Volume Overload: A Report from the Diabetes Collaborative Registry (DCR)

2019 · SUZANNE V. ARNOLD, MIKHAIL N. KOSIBOROD, et al. · Diabetes

Design, characterization and modulation of a novel heme-binding membrane protein

2008 · Jeanine M. Cordova

Works count: 18

Citation count: 248

H-index: 6

I10-index: 5